Table 2.
Coexistence of comorbidities in patients with psoriasis versus atopic dermatitis.
| Comorbidity | PsO | AD | p |
|---|---|---|---|
| Without comorbidities, n (%) | 19 (48.7) | 20 (50.0) | 0.261 |
| Hypertension, n (%) | 6 (15.4) | 5 (12.5) | |
| Diabetes, n (%) | 3 (7.7) | 0 (0) | |
| Obesity, n (%) | 2 (5.1) | 4 (10.0) | |
| Asthma, n (%) | 1 (2.6) | 2 (5.0) | |
| Hypertension + asthma, n (%) | 1 (2.6) | 5 (12.5) | |
| Hypertension + diabetes, n (%) | 5 (12.8) | 4 (10.0) | |
| Hypertension + fatty liver disease, n (%) | 2 (5.1) | 0 (0) | |
| Hypertension (total *), n (%) | 14 (35) | 14 (35) | 0.129 |
| Diabetes (total), n (%) | 8 (20) | 4 (10) | |
| Asthma (total), n (%) | 2 (5) | 7 (17.5) |
* total means as a single comorbidity or in combination with other comorbidities.